Top

Journal of Diabetes & Metabolic Disorders

Published in:

13-02-2023 | Angiography | Research article

Relationship of cardiovascular risk factors, pericardial fat, and carotid thickness with coronary plaque type in patients with diabetes mellitus

Authors: Hussein Nafakhi, Hayder Qassim Elwali, Kareem M Khalaf Al-Sharea, Abdulameer A Al-Mosawi

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2023

Abstract

Background

There is paucity of data on the potential predictors of coronary plaque types among patients with diabetes mellitus(DM).

Aims

To assess the association of cardiovascular risk factors, pericardial fat volume (PFV) assessed by multi-detector CT(MDCT)angiography, and internal carotid intima media thickness with coronary atherosclerotic plaque types in patients with type 2 DM.

Patients and methods

Patients with suspected coronary artery disease who underwent 64-slice MDCT angiography were enrolled in this retrospective study.

Results

A total of 784 patients were enrolled in this study, 198 of whom had DM and 586 of whom did not. The prevalence of calcified and mixed plaques was significantly higher in the DM group than without DM group, while no significant difference was found in the distribution of non-calcified plaque between groups. There was significant association between smoking [OR(CI) = 4(2–10),P = 0.001] and increased age[OR(CI) = 1.1(1-1.3),P = 0.023] and calcified plaque presence. Regarding mixed and non-calcified plaque, increased PFV[OR(CI) = 1.1(1-1.3),P = 0.001] and positive family history[OR(CI) = 4(2–12),P = 0.049] showed a significant association with coronary mixed plaque presence while no significant association was observed between cardiovascular risk factors, PFV, and internal carotid intima media thickness and non-calcified plaque presence in patients with DM.

Conclusion

Increased PFV showed significant and independent association with mixed coronary plaques development, which suggests that PFV may be used as an imaging marker for early detection of increased risk for future coronary events in patients with DM.

Khan A, Arbab-Zadeh A, Kiani AN, Magder LS, Petri M. Progression of noncalcified and calcified coronary plaque by CT angiography in SLE. Rheumatol Int. 2017;37(1):59–65. https://doi.org/10.1007/s00296-016-3615-z.CrossRefPubMed

Tsushima H, Yamamoto H, Kitagawa T, Urabe Y, Tatsugami F, Awai K, et al. Association of epicardial and abdominal visceral adipose tissue with coronary atherosclerosis in patients with a coronary artery calcium score of zero. Circ J. 2015;79:1084–91.CrossRefPubMed

Dwivedi A, Al’Aref SJ, Lin FY, Min JK. Evaluation of atherosclerotic plaque in non-invasive coronary imaging. Korean Circ J. 2018;48(2):124–33. https://doi.org/10.4070/kcj.2017.0392.CrossRefPubMedPubMedCentral

Jeevarethinam A, Venuraju S, Dumo A, Ruano S, Mehta VS, Rosenthal M, et al. Relationship between carotid atherosclerosis and coronary artery calcification in asymptomatic diabetic patients: a prospective multicenter study. Clin Cardiol. 2017;40(9):752–8. https://doi.org/10.1002/clc.22727.CrossRefPubMedPubMedCentral

Zellweger MJ, Maraun M, Osterhues HH, Keller U, Muller-Brand J, Jeger R, et al. Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy. J Am Coll Cardiol Img. 2014;7(10):1001–10.CrossRef

Feuchtner GM, Plank F, Beyer C, Barbieri F, Widmann G, Spitaler P, Dichtl W. Cardiac Computed Tomography: state of the Art and Future Horizons. J Clin Med. 2022;11(15):4429. https://doi.org/10.3390/jcm11154429.CrossRefPubMedPubMedCentral

Nafakhi H, Al-Mosawi AA, Mudhafar MM. Pericardial fat versus BMI in the assessment of coronary atherosclerotic burden in patients with diabetes mellitus. Acta Diabetol. 2020;57(5):605–11. https://doi.org/10.1007/s00592-019-01465-9.CrossRefPubMed

Tavares CA, Wajchjenberg BL, Rochitte C, Lerario AC. Screening for asymptomatic coronary artery disease in patients with type 2 diabetes mellitus. Arch Endocrinol Metab. 2016;60(2):143–51. https://doi.org/10.1590/2359-3997000000170.CrossRefPubMed

Kocak MZ, Aktas G, Duman TT, Atak BM, Kurtkulagi O, Tekce H, et al. Monocyte lymphocyte ratio as a predictor of Diabetic kidney Injury in type 2 diabetes mellitus; the MADKID Study. J Diabetes Metab Disord. 2020;19(2):997–1002. https://doi.org/10.1007/s40200-020-00595-0.CrossRefPubMedPubMedCentral

10.

Stojan G, Li J, Budoff M, Arbab-Zadeh A, Petri MA. High-risk coronary plaque in SLE: low-attenuation non-calcified coronary plaque and positive remodelling index. Lupus Sci Med. 2020;7(1):e000409. https://doi.org/10.1136/lupus-2020-000409.CrossRefPubMedPubMedCentral

11.

Williams MC, Kwiecinski J, Doris M, McElhinney P, D’Souza MS, Cadet S, et al. Low-attenuation Noncalcified Plaque on Coronary computed Tomography Angiography predicts myocardial infarction: results from the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART). Circulation. 2020;141(18):1452–62. https://doi.org/10.1161/CIRCULATIONAHA.119.044720.CrossRefPubMedPubMedCentral

12.

Christiansen MK, Jensen JM, Nørgaard BL, Dey D, Bøtker HE, Jensen HK. Coronary plaque burden and adverse plaque characteristics are increased in healthy relatives of patients with early onset coronary artery disease. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1128–35. https://doi.org/10.1016/j.jcmg.2016.10.014.CrossRefPubMed

13.

van Rosendael AR, Narula J, Lin FY, van den Hoogen IJ, Gianni U, Al Hussein Alawamlh O, et al. Association of High-Density calcified 1K plaque with risk of Acute Coronary Syndrome. JAMA Cardiol. 2020;5(3):282–90. https://doi.org/10.1001/jamacardio.2019.5315.CrossRefPubMedPubMedCentral

14.

Kral BG, Becker LC, Vaidya D, Yanek LR, Qayyum R, Zimmerman SL, et al. Noncalcified coronary plaque volumes in healthy people with a family history of early onset coronary artery disease. Circ Cardiovasc Imaging. 2014;7(3):446–53. https://doi.org/10.1161/CIRCIMAGING.113.000980. Epub 2014 Feb 27.CrossRefPubMedPubMedCentral

15.

Thomas IC, Forbang NI, Criqui MH. The evolving view of coronary artery calcium and cardiovascular disease risk. Clin Cardiol. 2018;41(1):144–50. https://doi.org/10.1002/clc.22842.CrossRefPubMedPubMedCentral

16.

Puri R, Nicholls SJ, Shao M, Kataoka Y, Uno K, Kapadia SR, et al. Impact of statins on serial coronary calcification during atheroma progression and regression. J Am Coll Cardiol. 2015;65(13):1273–82. https://doi.org/10.1016/j.jacc.2015.01.036.CrossRefPubMed

17.

Hou ZH, Lu B, Gao Y, Jiang SL, Wang Y, Li W, et al. Prognostic value of coronary CT angiography and calcium score for major adverse cardiac events in outpatients. JACC Cardiovasc Imaging. 2012;5(10):990–9. https://doi.org/10.1016/j.jcmg.2012.06.006.CrossRefPubMed

18.

Murai T, Takebe N, Nagasawa K, Todate Y, Nakagawa R, Nakano R, et al. Association of epicardial adipose tissue with serum level of cystatin C in type 2 diabetes. PLoS ONE. 2017;12(9):e0184723.CrossRefPubMedPubMedCentral

19.

Hwang IC, Park HE, Choi SY. Epicardial adipose tissue contributes to the development of non-calcified coronary plaque: a 5-Year computed Tomography follow-up study. J Atheroscler Thromb. 2017;24(3):262–74.CrossRefPubMedPubMedCentral

20.

Kim U, Leipsic JA, Sellers SL, Shao M, Blanke P, Hadamitzky M, et al. Natural history of Diabetic Coronary atherosclerosis by quantitative measurement of serial coronary computed Tomographic Angiography: results of the PARADIGM study. JACC Cardiovasc Imaging. 2018;11(10):1461–71. https://doi.org/10.1016/j.jcmg.2018.04.009.CrossRefPubMed

21.

Yang J, Dou G, Tesche C, De Cecco CN, Jacobs BE, Schoepf UJ, et al. Progression of coronary atherosclerotic plaque burden and relationship with adverse cardiovascular event in asymptomatic diabetic patients. BMC Cardiovasc Disord. 2019;19(1):39. https://doi.org/10.1186/s12872-019-1016-4.CrossRefPubMedPubMedCentral

22.

Yamaura H, Otsuka K, Ishikawa H, Shirasawa K, Fukuda D, Kasayuki N. Determinants of non-calcified low-attenuation coronary plaque burden in patients without known coronary artery disease: a coronary CT Angiography Study. Front Cardiovasc Med. 2022;9:824470. https://doi.org/10.3389/fcvm.2022.824470.CrossRefPubMedPubMedCentral

23.

Talman AH, Psaltis PJ, Cameron JD, Meredith IT, Seneviratne SK, Wong DT. Epicardial adipose tissue: far more than a fat depot. Cardiovasc Diagn Ther. 2014;4(6):416–29. https://doi.org/10.3978/j.issn.2223-3652.2014.11.05.CrossRefPubMedPubMedCentral

24.

Darabian S, Hormuz M, Latif MA, Pahlevan S, Budoff MJ. The role of carotid intimal thickness testing and risk prediction in the development of coronary atherosclerosis. Curr Atheroscler Rep. 2013;15(3):306. https://doi.org/10.1007/s11883-012-0306-4.CrossRefPubMedPubMedCentral

25.

Inaba Y, Chen JA, Bergmann SR. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis. 2012;220(1):128–33. https://doi.org/10.1016/j.atherosclerosis.2011.06.044.CrossRefPubMed

26.

Cohen GI, Aboufakher R, Bess R, Frank J, Othman M, Doan D, et al. Relationship between carotid disease on ultrasound and coronary disease on CT angiography. JACC Cardiovasc Imaging. 2013;6(11):1160–7. https://doi.org/10.1016/j.jcmg.2013.06.007.CrossRefPubMed

27.

Kathiresan S, Larson MG, Keyes MJ, Polak JF, Wolf PA, D’Agostino RB, et al. Assessment by cardiovascular magnetic resonance, electron beam computed tomography, and carotid ultrasonography of the distribution of subclinical atherosclerosis across Framingham risk strata. Am J Cardiol. 2007;99(3):310–4. https://doi.org/10.1016/j.amjcard.2006.08.028.CrossRefPubMed

28.

Bytyçi I, Shenouda R, Wester P, Henein MY. Carotid atherosclerosis in Predicting Coronary Artery Disease: a systematic review and Meta-analysis. Arterioscler Thromb Vasc Biol. 2021;41(4):e224–37. https://doi.org/10.1161/ATVBAHA.120.315747.CrossRefPubMed

Title: Relationship of cardiovascular risk factors, pericardial fat, and carotid thickness with coronary plaque type in patients with diabetes mellitus
Authors: Hussein Nafakhi
Hayder Qassim Elwali
Kareem M Khalaf Al-Sharea
Abdulameer A Al-Mosawi
Publication date: 13-02-2023
Publisher: Springer International Publishing
Keywords: Angiography
Arterial Occlusive Disease
Diabetes
Published in: Journal of Diabetes & Metabolic Disorders / Issue 1/2023
Electronic ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-023-01190-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Aims

Patients and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

Effect of novel Matrix Rhythm Therapy (MaRhyThe®) on neuropathic pain and maximum plantar pressure distribution among type 2 diabetes mellitus patients with peripheral neuropathy

The combined role of diabetes and obesity in susceptibility to musculoskeletal disorders and its subtypes in older men and women in India

A bibliometric perspective to the most cited diabetes articles

Beneficial effects of 1,3–1,6 β-glucans produced by Aureobasidium pullulans on non-esterified fatty acid levels in diabetic KKAy mice and their potential implications in metabolic dysregulation

Association between serum interleukin-6, leptin and insulin in gestational diabetes mellitus – a cross- sectional study

The Iranian blood pressure measurement campaign, 2019: study protocol and preliminary results

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials